app-store-icon play-store-icon
Zydus Life launches trivalent influenza vaccine 'VaxiFlu' in India

If you are a professional stock trader or if you track the equity market actively, check out our Real-time EquityWireIf you track the bond or forex market or the macro economy actively, check out our Real-time MoneyWireIf you track agri commodities, precious metals or base metals actively, check out our Real-time CommodityWire

Please register for a 30-day free trial. Click here

Zydus Life launches trivalent influenza vaccine 'VaxiFlu' in India

This story was originally published at 13:35 IST on September 2, 2025  Back
Register to read our real-time news.


Zydus Lifesciences Ltd. Tuesday said it has launched trivalent influenza vaccine, VaxiFlu, for the first time in India. It is used to treat flu, which is a significant global health concern of seasonal influenza annually, the company said in an exchange filing.

To read our premium stories please subscribe.